Abstract
EP.08F.14 Outcomes of Durvalumab Consolidation Treatment in Stage III Unresectable NSCLC: A Retrospective Real-World Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have